MedCity News January 20, 2026
Katie Adams

French startup Naox Technologies this month became the first company to receive FDA 510(k) clearance for an in-ear EEG device. The system seeks to improve care for neurological conditions like epilepsy, Alzheimer’s and sleep disorders by capturing brain activity in everyday settings that traditional scalp-based EEGs often miss.

French medtech startup Naox Technologies this month became the first company to receive FDA 510(k) clearance for an in-ear electroencephalogram (EEG) device — a move that could shift brain monitoring away from bulky, scalp-based EEG systems to a compact ear-worn platform.

Unlike traditional EEG systems that use upwards of 20 scalp electrodes, Naox’s device aims to be comfortable and is easy for patients to apply by themselves. The device captures electrical brain...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: FDA, Govt Agencies, Medical Devices
Related Articles:
AI Model FDA-Cleared to Triage 14 Conditions
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 2)
FDA Updates Two Digital Health Final Guidance Documents
FDA in Flux — January 2026 Newsletter
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 1)

Share Article